BGC
AMAG

Birch Grove Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Birch Grove Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-45,000
Closed -$11K – 19
2019
Q4 		$11K Sell
45,000
-75,000
-63% -$820K 0.01% 14
2019
Q3 		$71K Buy
+120,000
New +$1.26M 0.05% 21
2016
Q4 		– Sell
-207,000
Closed -$62K – 20
2016
Q3 		$62K Hold
207,000
– – 0.06% 15
2016
Q2 		$228K Buy
+207,000
New +$4.75M 0.12% 18

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return